Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.45) by 38.64 percent. This is a 40 percent increase over losses of $(0.45) per share from the same period last year. The company reported quarterly sales of $2.510 million which beat the analyst consensus estimate of $420.000 thousand by 497.62 percent. This is a 15.72 percent increase over sales of $2.169 million the same period last year.